Organ-preserving multimodal therapy for patients with high-risk upper tract urothelial carcinoma in China (DISTINCT-I): a single-arm, phase 2 trial
The publisher did not provide an abstract — full text is available via the link below.
The publisher did not provide an abstract — full text is available via the link below.